Portal hypertension (PH) is a frequent complication of cirrhosis, contributing to the development of ascites, esophageal varices (EV), and hepatic encephalopathy.

Slides:



Advertisements
Similar presentations
Non Cirrhotic Portal Hypertension: A Serious Hepatic Complication in HIV and the Use of Transient Elastography for Diagnosis Dronamraju D,Vachon ML, and.
Advertisements

ALCOHOLIC LIVER DISEASE: Diagnostics: – ROUTINE SCREENING TEST LABORATORY DIAGNOSIS OF ALCOHOLIC FATTY LIVER AND ALCOHOLIC HEPATITIS TESTCOMMENT ASTIncreased.
Clinical Course of Untreated BA Phoebe part. Clinical Course of Untreated BA Most present within four to six weeks of conjugated jaundice and acholic.
Measurement of liver fibrosis Amar Dhillon Royal Free and University College Medical School.
V. Petrenkiene*, D. Petrauskas L. Kupcinskas, Lithuanian University of Health sciences Clinic of Gastroenterology Kaunas Utility of non-invasive markers.
© 2010 Pearson Prentice Hall. All rights reserved Regression Interval Estimates.
Liver Cirrhosis S. Diana Garcia
International Congress Highlights 2004 Clinical Update in GI disease Portal Hypertension P. Michielsen University of Antwerp
SERUM VISFATIN CONCENTRATION IS ASSOCIATED WITH AN ATHEROGENIC METABOLIC PROFILE T.D. Filippatos 1, A. Liontos 1, F. Barkas 1, E. Klouras 1, V. Tsimihodimos.
Primary Sclerosing Cholangitis
FT in prognostic of HBV FibroTest: predictive value in HBV.
Evaluating the Patient With Abnormal Liver Tests-2 פרופ ' צבי אקרמן מבית חולים הדסה הר הצופים.
CIRRHOSIS DR.AMANULLAH ABBASI FCPS, MRCP SENIOR REGISTRAR WARD-7 JPMC.
Progressive histological liver improvement after sustained virological response to therapy in HCV / HIV coinfected patients. Jose L. Casado,
RELEVANCERELEVANCE Is the objective of the article on harm similar to your clinical dilemma? Yes, the article’s objective is similar to the clinical dilemma.
Dr. Ravi kant Assistant Professor Department of General Medicine.
Regression David Young & Louise Kelly Department of Mathematics and Statistics, University of Strathclyde Royal Hospital for Sick Children, Yorkhill NHS.
CIRRHOSISPathophysiology&Complications. Normal liver functions Carbohydrate Metabolism Hypo- or hyperglycemia Fatty Acids Metabolism Lipid Transport.
Non-Invasive Liver Testing
LIVER HEALTH an integral part of CF gastrointestinal care Zachary M Sellers, MD, PhD Fellow Pediatric Gastroenterology, Hepatology, and Nutrition Stanford.
Nonalcoholic Fatty Liver Disease / Nonalcoholic Steatohepatitis 소화기내과 R3 신아리 1.
Liver Stiffness Measurement Using Acoustic Radiation Force Impulse (ARFI) Elastography and Effect of Necroinflammation Ki Tae Yoon, Sun Min Lim,Jun Yong.
Definition  Is a chronic disease characterized by scaring and necrotic tissue replaced by fibrotic tissue. Resulting in hepatic insufficiency and portal.
Dominique Valla, Richard Moreau, and Didier Lebrec
Noncirrhotic portal hypertension (NCPH) comprises diseases of the liver manifesting with portal hypertension due to intrahepatic.
HEPATOLOGY, Vol. 61, No. 6, Introduction At least 1 / 3 of liver cirrhosis (LC) Chronic hepatitis B (CHB) Significant proportion of CHB progress.
Stats Methods at IC Lecture 3: Regression.
Screening System for Hypertension and Diabetes at Primary Care Level
Spleen Enlargement on Follow-Up Evaluation: A Noninvasive Predictor of Complications of Portal Hypertension in Cirrhosis  Annalisa Berzigotti, Paola Zappoli,
Diagnostic accuracy and statistical significance
Non-Invasive Assessment of PSC Progression
Portal Hypertension.
Diagnostic test accuracy. Study design and the 2x2 table
Figure 1 Proposed risk stratification for patients with NAFLD
The Value of Measurement of Circulating Tumor Cells in Hepatocellular Carcinoma Nashwa Sheble, Gehan Hamdy, Moones A Obada, Gamal Y Abouria, Fatma Khalaf.
Portal hypertension.
Cirrhosis Key features:
Non-invasive assessment of
Volume 139, Issue 6, Pages (December 2010)
University of Medicine and Pharmacy “Carol Davila”, Bucharest
THE NEED OF A NEW PATHOPHYSIOLOGICAL CLASSIFICATION OF CIRRHOSIS
Longitudinal Transient Elastography measurements (Fibroscan) used in follow-up for patients with Cystic Fibrosis. Stephanie Van Biervliet, Hugo Verdievel,
GASTROENTEROLOGY 2009;137:892–901 R2. 정 회 훈.
Samantha King, Jill Jones MD, Russ Waitman PhD
Understanding Standards Event Higher Statistics Award
Managing Complications of Cirrhosis
Update on ultrasound imaging of liver fibrosis
Volume 133, Issue 2, Pages (August 2007)
The receiver operating characteristic (ROC) curve
Spleen Enlargement on Follow-Up Evaluation: A Noninvasive Predictor of Complications of Portal Hypertension in Cirrhosis  Annalisa Berzigotti, Paola Zappoli,
Assessment of Hepatic Fibrosis With Magnetic Resonance Elastography
Accuracy of Spleen Stiffness Measurement in Detection of Esophageal Varices in Patients With Chronic Liver Disease: Systematic Review and Meta-analysis 
Figure 1 Proposed algorithm for the management
CIRRHOSIS Ahmed Salam Lectures Medical Student “TSU”
IMAGING-BASED MODALITIES IN NAFLD
Liver cancer: Approaching a personalized care
Volume 146, Issue 4, Pages e6 (April 2014)
Care of Patients with Liver Problems
Internal medicine L-4 Liver cirrhosis & portal hypertension
Clinical states of cirrhosis and competing risks
Hepatic Vein Pressure Gradient Reduction and Prevention of Variceal Bleeding in Cirrhosis: A Systematic Review  Gennaro D’Amico, Juan Carlos Garcia-Pagan,
Volume 144, Issue 1, Pages e1 (January 2013)
Volume 133, Issue 2, Pages (August 2007)
New Direct-Acting Antiviral Agents Can Be Hepatotoxic in Patients With Hepatitis C Virus Infection and Decompensated Cirrhosis  Pengcheng Ou, MD, Fangfang.
Non-invasive evaluation of liver fibrosis using transient elastography
Accuracy of Spleen Stiffness Measurement in Detection of Esophageal Varices in Patients With Chronic Liver Disease: Systematic Review and Meta-analysis 
Volume 143, Issue 3, Pages (September 2012)
Laurent Castera, Mireen Friedrich-Rust, Rohit Loomba  Gastroenterology 
Douglas A. Simonetto, MD, Mengfei Liu, MD, Patrick S. Kamath, MD 
LIVER CIRRHOSIS IN PSC: DIAGNOSIS AND MANAGEMENT
Presentation transcript:

Portal hypertension (PH) is a frequent complication of cirrhosis, contributing to the development of ascites, esophageal varices (EV), and hepatic encephalopathy.

The hepatic vein pressure gradient (HVPG) is the standard used to determine the degree of portal hypertension (PH) and an important prognostic factor for patients with cirrhosis.

. However, HVPG can only be accurately determined at specialized centers; noninvasive methods are needed to predict HVPG values and the presence of EV.

However, the performance of HVPG is limited to highly specialized centers and requires extensive experience and therefore is not used routinely.

splenomegaly in cirrhosis is characterized by enlargement and hyperactivation of the splenic lymphoid tissue, as well as increased angiogenesis and fibrogenesis, in addition to passive congestion due to PH. spleen stiffness (SS), assessed by magnetic resonance elastography.

SS values were obtained using the FibroScan with the same probe used to perform LS after at least 6 hours of fasting and under US assistance. In the absence of guidelines for the measurement of SS by FibroScan, the same guidelines for the measurement of LS were applied.

the aim of this study was to assess the relationship between SS measured by TE (FibroScan; Echosens, Paris, France) and PH in terms of HVPG together with the possibility of predicting the presence of EV according to SS in a cohort of 100 consecutive patients with hepatitis C virus (HCV)-related cirrhosis without clinically evident complications. The study was performed in a tertiary center: the Department of Clinical Medicine of the University of Bologna (Italy).

Each patient was studied according to a 3-day protocol as follows: day 1 included clinical and biochemical evaluation, complete abdominal US, and measurement of LS and SS by TE; day 2 included measurement of HVPG; and day 3 included upper digestive endoscopy.

patients with a splenic parenchymal thickness of <4 cm under the probe were excluded. Other exclusion criteria were the presence of ascites, severe obesity, and the absence of an intercostal space sufficiently wide for the use of the FibroScan probe.

Figure 1. Flow chart of the studied patients.

A first interesting observation of this study is the high diagnostic accuracy of SS, in terms of AUROC, for both the diagnosis of EV and the definition of the degree of PH (HVPG ≥10 or ≥12 mm Hg). Particularly concerning the diagnosis of EV, an SS cutoff value 41.3.

even more interesting is the possibility to assess noninvasively HVPG by measurement of SS and LS. In fact, with a simple linear model including both variables, it seems possible to obtain an accurate estimate of HVPG. Predictive equation: HVPG = − LS SS.

SS reflects the changes in splanchnic hemodynamics leading to the formation of EV better than LS and any other noninvasive parameter investigated in the present study.